{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:02:28Z","timestamp":1791226948955,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research (CA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute (CA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network (CA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004203","name":"Ontario Institute for Cancer Research (CA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11060-015-1951-6","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T07:30:17Z","timestamp":1445671817000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A novel stem cell culture model of recurrent glioblastoma"],"prefix":"10.1007","volume":"126","author":[{"given":"Maleeha A.","family":"Qazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minomi K.","family":"Subapanditha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh K.","family":"Murty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O\u2019Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research N (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110. doi: 10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"},{"key":"1951_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.neuro.24.1.385","volume":"24","author":"R Wechsler-Reya","year":"2001","unstructured":"Wechsler-Reya R, Scott MP (2001) The developmental biology of brain tumors. Annu Rev Neurosci 24:385\u2013428. doi: 10.1146\/annurev.neuro.24.1.385","journal-title":"Annu Rev Neurosci"},{"key":"1951_CR3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrc866","volume":"2","author":"Y Zhu","year":"2002","unstructured":"Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2:616\u2013626. doi: 10.1038\/nrc866","journal-title":"Nat Rev Cancer"},{"key":"1951_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","volume":"10","author":"JT Huse","year":"2010","unstructured":"Huse JT, Holland EC (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10:319\u2013331. doi: 10.1038\/nrc2818","journal-title":"Nat Rev Cancer"},{"key":"1951_CR5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, EuropeanOrganisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. doi: 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"1951_CR6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research N","year":"2008","unstructured":"Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061\u20131068. doi: 10.1038\/nature07385","journal-title":"Nature"},{"key":"1951_CR7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396\u2013401. doi: 10.1038\/nature03128","journal-title":"Nature"},{"key":"1951_CR8","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821\u20135828","journal-title":"Cancer Res"},{"key":"1951_CR9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.stem.2009.03.003","volume":"4","author":"MJ Son","year":"2009","unstructured":"Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440\u2013452. doi: 10.1016\/j.stem.2009.03.003","journal-title":"Cell Stem Cell"},{"key":"1951_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.stem.2010.02.018","volume":"6","author":"JD Lathia","year":"2010","unstructured":"Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6:421\u2013432. doi: 10.1016\/j.stem.2010.02.018","journal-title":"Cell Stem Cell"},{"key":"1951_CR11","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1158\/0008-5472.CAN-08-1079","volume":"68","author":"S Bao","year":"2008","unstructured":"Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68:6043\u20136048. doi: 10.1158\/0008-5472.CAN-08-1079","journal-title":"Cancer Res"},{"key":"1951_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000017435","volume":"22","author":"Y Kaneko","year":"2000","unstructured":"Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H (2000) Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139\u2013153","journal-title":"Dev Neurosci"},{"key":"1951_CR13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0896-6273(03)00497-5","volume":"39","author":"V Graham","year":"2003","unstructured":"Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39:749\u2013765","journal-title":"Neuron"},{"key":"1951_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2007.04.001","volume":"1","author":"CA Fasano","year":"2007","unstructured":"Fasano CA, Dimos JT, Ivanova NB, Lowry N, Lemischka IR, Temple S (2007) shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 1:87\u201399. doi: 10.1016\/j.stem.2007.04.001","journal-title":"Cell Stem Cell"},{"key":"1951_CR15","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1523\/JNEUROSCI.0968-09.2009","volume":"29","author":"M Abdouh","year":"2009","unstructured":"Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884\u20138896. doi: 10.1523\/JNEUROSCI.0968-09.2009","journal-title":"J Neurosci"},{"key":"1951_CR16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suva","year":"2014","unstructured":"Suva ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, Beik S, Kadri S, Tirosh I, Wortman I, Shalek AK, Rozenblatt-Rosen O, Regev A, Louis DN, Bernstein BE (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157:580\u2013594. doi: 10.1016\/j.cell.2014.02.030","journal-title":"Cell"},{"key":"1951_CR17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","volume":"5","author":"G Liu","year":"2006","unstructured":"Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Molecular cancer 5:67. doi: 10.1186\/1476-4598-5-67","journal-title":"Molecular cancer"},{"key":"1951_CR18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756\u2013760. doi: 10.1038\/nature05236","journal-title":"Nature"},{"key":"1951_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.scr.2011.09.008","volume":"8","author":"C Venugopal","year":"2012","unstructured":"Venugopal C, Li N, Wang X, Manoranjan B, Hawkins C, Gunnarsson T, Hollenberg R, Klurfan P, Murty N, Kwiecien J, Farrokhyar F, Provias JP, Wynder C, Singh SK (2012) Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells. Stem Cell Res 8:141\u2013153. doi: 10.1016\/j.scr.2011.09.008","journal-title":"Stem Cell Res"},{"key":"1951_CR20","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-07-6878","volume":"68","author":"D Beier","year":"2008","unstructured":"Beier D, Rohrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP (2008) Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 68:5706\u20135715. doi: 10.1158\/0008-5472.CAN-07-6878","journal-title":"Cancer Res"},{"key":"1951_CR21","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.1999.17.8.2604","volume":"17","author":"LA Hammond","year":"1999","unstructured":"Hammond LA, Eckardt JR, Baker SD, Eckhardt SG, Dugan M, Forral K, Reidenberg P, Statkevich P, Weiss GR, Rinaldi DA, Von Hoff DD, Rowinsky EK (1999) Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies. J Clin Oncol 17:2604\u20132613","journal-title":"J Clin Oncol"},{"key":"1951_CR22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1667\/RR2803.1","volume":"177","author":"L Barazzuol","year":"2012","unstructured":"Barazzuol L, Jena R, Burnet NG, Jeynes JC, Merchant MJ, Kirkby KJ, Kirkby NF (2012) In vitro evaluation of combined temozolomide and radiotherapy using X rays and high-linear energy transfer radiation for glioblastoma. Radiat Res 177:651\u2013662","journal-title":"Radiat Res"},{"key":"1951_CR23","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet JP, Tamayo P, Golub TR, Mesirov JP (2004) Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci USA 101:4164\u20134169. doi: 10.1073\/pnas.0308531101","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR24","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/gb-2012-13-12-r112","volume":"13","author":"G Wu","year":"2012","unstructured":"Wu G, Stein L (2012) A network module-based method for identifying cancer prognostic signatures. Genome Biol 13:R112. doi: 10.1186\/gb-2012-13-12-r112","journal-title":"Genome Biol"},{"key":"1951_CR25","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/gb-2010-11-5-r53","volume":"11","author":"G Wu","year":"2010","unstructured":"Wu G, Feng X, Stein L (2010) A human functional protein interaction network and its application to cancer data analysis. Genome Biol 11:R53. doi: 10.1186\/gb-2010-11-5-r53","journal-title":"Genome Biol"},{"key":"1951_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","volume":"469","author":"F Notta","year":"2011","unstructured":"Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, Ma J, Minden MD, Downing JR, Dick JE (2011) Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469:362\u2013367. doi: 10.1038\/nature09733","journal-title":"Nature"},{"key":"1951_CR27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","volume":"58","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267\u2013284. doi: 10.1146\/annurev.med.58.062105.204854","journal-title":"Annu Rev Med"},{"key":"1951_CR28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2011.09.025","volume":"19","author":"K Barami","year":"2012","unstructured":"Barami K, Fernandes R (2012) Incidence, risk factors and management of delayed wound dehiscence after craniotomy for tumor resection. J Clin Neurosci 19:854\u2013857. doi: 10.1016\/j.jocn.2011.09.025","journal-title":"J Clin Neurosci"},{"key":"1951_CR29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3171\/jns.2003.98.6.1175","volume":"98","author":"SM Chang","year":"2003","unstructured":"Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M, Glioma Outcomes I (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175\u20131181. doi: 10.3171\/jns.2003.98.6.1175","journal-title":"J Neurosurg"},{"key":"1951_CR30","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1523\/JNEUROSCI.1634-10.2010","volume":"30","author":"S Facchino","year":"2010","unstructured":"Facchino S, Abdouh M, Chatoo W, Bernier G (2010) BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 30:10096\u201310111. doi: 10.1523\/JNEUROSCI.1634-10.2010","journal-title":"J Neurosci"},{"key":"1951_CR31","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.ejca.2013.05.013","volume":"49","author":"AT Tandle","year":"2013","unstructured":"Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013) Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer 49:3020\u20133028. doi: 10.1016\/j.ejca.2013.05.013","journal-title":"Eur J Cancer"},{"key":"1951_CR32","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/stem.1081","volume":"30","author":"C Lee","year":"2012","unstructured":"Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE (2012) Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice. Stem Cells 30:1064\u20131075. doi: 10.1002\/stem.1081","journal-title":"Stem Cells"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1951-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1951-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:22:55Z","timestamp":1559348575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1951-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1951-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}